Current Research Information SysTem In Norway
 
 

 English version


 
Hovedside
Forskningsresultater/NVI
Forskere
Prosjekter
Forskningsenheter
Logg inn
Om Cristin
 
 
   
Eksporter til


Viser treff 1-50 av 79 << Forrige 1 2    Neste >>

2023
1 Dahl, Alv A; Smeland, Knut Bjøro; Eikeland, Siri Asheim; Fagerli, Unn Merete; Bersvendsen, Hanne Skjerven; Fosså, Alexander; Kiserud, Cecilie E..
Work ability and work status changes in long-term Hodgkin lymphoma survivors with focus on late adverse effects. Journal of cancer survivorship 2023 ;Volum 0. s. 1-10
OUS STO UNN UiO Untitled
 
2 Eikeland, Siri Asheim; Smeland, Knut Bjøro; Simensen, Victoria Charlotte; Fagerli, Unn Merete; Bersvendsen, Hanne Skjerven; Kiserud, Cecilie E.; Fosså, Alexander.
Chronic fatigue in long-term survivors of Hodgkin’s lymphoma after contemporary risk-adapted treatment. Acta Oncologica 2023 ;Volum 62.(1) s. 80-88
OUS UiO FHI NTNU STO UNN Untitled
 
3 Lia, Kjersti; R.K. Jørgensen, Rasmus; Wold, Bente Loftum; Fluge, Øystein; Fagerli, Unn Merete; Bersvendsen, Hanne Skjerven; Bø, Idun Bakke; Bhargava, Sameer; Fosså, Alexander.
Overall survival and causes of death in elderly patients with Hodgkin lymphoma: a Norwegian population-based case-control study. Haematologica 2023 ;Volum 00.(xx)
AHUS UiO HAUKELAND STO VV UNN KREFTREG SUS OUS Untitled
 
2022
4 Husby, Trine; Johansen, Håkon; Bogsrud, Trond; Hustad, Kari Vekseth; Evensen, Birte Veslemøy; Boellaard, Ronald; Giskeødegård, Guro F.; Fagerli, Unn-Merete; Eikenes, Live.
Prognostic value of combined MTV and ADC derived from baseline FDG PET/MRI in aggressive non-Hodgkins lymphoma. BMC Cancer 2022 ;Volum 22.(1) s. -
NTNU STO UNN Untitled
 
5 Husby, Trine; Johansen, Håkon; Bogsrud, Trond; Hustad, Kari Vekseth; Evensen, Birte Veslemøy; Boellard, Ronald; Giskeødegård, Guro F.; Fagerli, Unn-Merete; Eikenes, Live.
A comparison of FDG PET/MR and PET/CT for staging, response assessment, and prognostic imaging biomarkers in lymphoma. Annals of Hematology 2022 ;Volum 101.(5) s. 1077-1088
NTNU STO UNN Untitled
 
6 Smeland, Knut Bjøro; Holte, Harald; Fagerli, Unn-Merete; Bersvendsen, Hanne Skjerven; Hjermstad, Marianne Jensen; Loge, Jon Håvard; Murbræch, Klaus; Linnsund, Marianne Dahl; Fluge, Øystein; Stenehjem, Jo Steinson; Samersaw-Lund, May Brit; Kvaløy, Stein Olav; Kiserud, Cecilie E..
Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life. Haematologica 2022 ;Volum 107.(11) s. 2698-2707
OUS UiO NTNU STO UNN AHUS HAUKELAND KREFTREG Untitled
 
2021
7 Eikeland, Siri Asheim; Smeland, Knut Bjøro; Mols, Floortje; Fagerli, Unn-Merete; Bersvendsen, Hanne Skjerven; Kiserud, Cecilie E.; Fosså, Alexander.
Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin’s lymphoma; symptom burden and quality of life. Acta Oncologica 2021 ;Volum 60.(7) s. 911-920
OUS UiO NTNU STO UNN Untitled
 
8 Hernæs, Kjersti Helene; Smeland, Knut Bjøro; Fagerli, Unn-Merete; Kiserud, Cecilie E..
Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation. BMC Cancer 2021 ;Volum 21.(1) s. -
OUS FHI NTNU STO Untitled
 
9 Åsberg, Arne; Løfblad, Lena; Felic, Amela; Aune, Marthe Wedø; Hov, Gunhild Garmo; Fagerli, Unn-Merete.
Using blood calprotectin as a measure of blood neutrophils. Scandinavian Journal of Clinical and Laboratory Investigation 2021 ;Volum 81.(4) s. 303-306
STO NTNU Untitled
 
2020
10 Bersvendsen, Hanne Skjerven; Haugnes, Hege Sagstuen; Dahl, Alv A; Fagerli, Unn-Merete; Fluge, Øystein; Holte, Harald; Wilsgaard, Tom; Smeland, Knut Bjøro; Kiserud, Cecilie E..
Sexual dysfunction is prevalent in female lymphoma survivors after autologous stem-cell transplantation and is associated with younger age, chronic fatigue, and mental distress. Bone Marrow Transplantation 2020 s. 1-3
UiT UNN UiO OUS NTNU STO HAUKELAND Untitled
 
11 Kolstad, Arne; Illidge, Tim; Bolstad, Nils; Spetalen, Signe; Madsbu, Ulf Erik; Stokke, Caroline; Blakkisrud, Johan; Løndalen, Ayca Muftuler; O'Rourke, Noelle; Beasley, Matthew; Jurczak, Wojciech; Fagerli, Unn-Merete; Kascak, Michal; Bayne, Mike; Obr, Ales; Dahle, Jostein; Rojkjaer, Lisa; Pascal, Veronique; Holte, Harald.
Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma. Blood Advances 2020 ;Volum 4.(17) s. 4091-4101
NTNU STO OUS Untitled
 
12 Leppä, Sirpa; Jørgensen, Judit; Tierens, Anne; Meriranta, Leo; Østlie, Ingunn; Brown, Peter de Nully; Fagerli, Unn-Merete; Larsen, Thomas Stauffer; Mannisto, Susanna; Munksgaard, Lars; Maisenhölder, Martin; Vasala, Kaija; Meyer, Peter Albert; Jerkeman, Mats; Björkholm, Magnus; Fluge, Øystein; Jyrkkiö, Sirkku; Liestøl, Knut; Ralfkiaer, Elisabeth; Spetalen, Signe; Beiske, Klaus; Karjalainen-Lindsberg, Marja-Liisa; Holte, Harald.
Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis. Blood Advances 2020 ;Volum 4.(9) s. 1906-1915
UNN UiO HAUKELAND STO SUS OUS Untitled
 
2019
13 Bersvendsen, Hanne Skjerven; Haugnes, Hege Sagstuen; Dahl, Alv A; Fagerli, Unn-Merete; Fluge, Øystein; Holte, Harald; Seland, Mette; Wilsgaard, Tom; Smeland, Knut Bjøro; Kiserud, Cecilie E..
Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation. Bone Marrow Transplantation 2019 s. 1-15
UiT UNN OUS UiO NTNU STO HAUKELAND Untitled
 
14 Bersvendsen, Hanne Skjerven; Haugnes, Hege Sagstuen; Fagerli, Unn-Merete; Fluge, Øystein; Holte, Harald; Smeland, Knut Bjøro; Wilsgaard, Tom; Kiserud, Cecilie E..
Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes. Acta Oncologica 2019 ;Volum 58.(5) s. 690-699
UiT UNN NTNU STO HAUKELAND OUS UiO Untitled
 
15 Fosså, Alexander; Smeland, Knut; Fagerli, Unn-Merete; Galleberg, Renate Berget; Bersvendsen, Hanne Skjerven; Holte, Harald.
Brentuximab vedotin in relapsed or refractory classical hodgkin lymphoma: real life experience in Norway 2011–2016. Acta Oncologica 2019 ;Volum 59.(1) s. 101-105
OUS STO HAUKELAND UNN UiO Untitled
 
16 Simensen, Victoria C; Smeland, Knut Bjøro; Kiserud, Cecilie E.; Dahl, Alv A; Bersvendsen, Hanne Skjerven; Fluge, Øystein; Fagerli, Unn-Merete; Fosså, Alexander.
Survivors' knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma. Acta Oncologica 2019 ;Volum 58.(9) s. 1315-1322
OUS UNN STO UiO NTNU HAUKELAND Untitled
 
2018
17 Hjort, Magnus Aasved; Hov, Håkon; Abdollahi, Pegah; Vandsemb, Esten; Fagerli, Unn-Merete; Lund, Bendik; Slørdahl, Tobias Schmidt; Børset, Magne; Rø, Torstein Baade.
Phosphatase of regenerating liver -3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration. SIOP 2018; 2018-11-16 - 2018-11-19
NTNU STO Untitled
 
18 Hjort, Magnus Aasved; Hov, Håkon; Abdollahi, Pegah; Vandsemb, Esten; Fagerli, Unn-Merete; Lund, Bendik; Slørdahl, Tobias Schmidt; Børset, Magne; Rø, Torstein Baade.
Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration. Experimental hematology and oncology 2018 ;Volum 7:8. s. 1-13
NTNU STO Untitled
 
19 Smeland, Knut Bjøro; Loge, Jon Håvard; Aass, Hans Christian Dalsbotten; Aspelin, Trude; Bersvendsen, Hanne Skjerven; Bolstad, Nils; Fagerli, Unn-Merete; Falk, Ragnhild Sørum; Fluge, Øystein; Fosså, Alexander; Holte, Harald; Lund, May-Brith; Murbræch, Klaus; Reinertsen, Kristin Valborg; Stenehjem, Jo Steinson; Kiserud, Cecilie E..
Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity. Bone Marrow Transplantation 2018 s. 1-4
OUS UiO STO UNN NTNU UiB KREFTREG Untitled
 
2016
20 Kiserud, Cecilie E.; Fagerli, Unn-Merete; Smeland, Knut Bjøro; Fluge, Øystein; Bersvendsen, Hanne; Kvaløy, Stein Olav; Holte, Harald; Dahl, Alv A.
Pattern of employment and associated factors in long-term lymphoma survivors 10 years after high-dose chemotherapy with autologous stem cell transplantation. Acta Oncologica 2016 ;Volum 55.(5) s. 547-553
OUS NTNU UiO UNN STO HAUKELAND Untitled
 
21 Kolstad, Arne; Pedersen, Lone Bredo; Eskelund, Christian W.; Husby, Simon; Grønbæk, Kirsten; Jerkeman, Mats; Laurell, Anna; Räty, Riikka; Elonen, Erkki; Andersen, Niels Smedegaard; Brown, Peter deNully; Kimby, Eva; Bentzen, Hans; Sundström, Christer; Ehinger, Mats; Karjalainen-Lindsberg, Marja-Liisa; Delabie, Jan; Ralfkiær, Elisabeth; Fagerli, Unn-Merete; Nilsson-Ehle, Herman; Lauritzsen, Grete Fossum; Kuittinen, Outi; Niemann, Carsten; Geisler, Christian Hartman; Nordic Lymphoma Group, for the.
Molecular monitoring after autologous stem cell transplantation and preemptive Rituximab treatment of molecular relapse; results from the Nordic mantle cell lymphoma studies (MCL2 and MCL3) with median follow-up of 8.5 years. Biology of Blood and Marrow Transplantation 2016 ;Volum 23.(3) s. 428-435
STO OUS Untitled
 
22 Smeland, Knut Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Blystad, Anne Kirsti; Fagerli, Unn-Merete; Falk, Ragnhild Sørum; Fluge, Øystein; Fosså, Alexander; Kolstad, Arne; Loge, Jon Håvard; Maisenhölder, Martin; Østenstad, Bjørn; Kvaløy, Stein Olav; Holte, Harald.
A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma. British Journal of Haematology 2016 ;Volum 173.(3) s. 432-443
UiO OUS NTNU UNN STO HAUKELAND Untitled
 
2015
23 Aasheim, Lars Birger; Karlberg, Anna; Goa, Pål Erik; Håberg, Asta; Sørhaug, Sveinung; Fagerli, Unn-Merete; Eikenes, Live.
PET/MR - utfordringer og potensiale. Bestpractice Onkologi/Hematologi 2015 (21) s. 10-12
NTNU STO Untitled
 
24 Aasheim, Lars Birger; Karlberg, Anna; Goa, Pål Erik; Håberg, Asta; Sørhaug, Sveinung; Fagerli, Unn-Merete; Eikenes, Live.
PET/MR brain imaging: evaluation of clinical UTE-based attenuation correction. European Journal of Nuclear Medicine and Molecular Imaging 2015 ;Volum 42.(9) s. 1439-1446
NTNU STO Untitled
 
25 Pulczynski, Elisa J.; Kuittinen, Outi; Erlanson, Martin; Hagberg, Hans; Fosså, Alexander; Eriksson, Mikael; Nordström, Marie; Østenstad, Bjørn; Fluge, Øystein; Leppä, Sirpa; Fiirgaard, Bente; Bersvendsen, Hanne; Fagerli, Unn-Merete.
Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group. Haematologica 2015 ;Volum 100.(4) s. 534-540
OUS NTNU HAUKELAND UNN STO Untitled
 
26 Smeland, Knut Halvor Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Fagerli, Unn-Merete; Falk, Ragnhild Sørum; Fluge, Øystein; Fosså, Alexander; Kolstad, Arne; Loge, Jon Håvard; Maisenhölder, Martin; Kvaløy, Stein Olav; Holte, Harald.
Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway. Haematologica 2015 ;Volum 100.(6) s. e240-e243
STO UiO HAUKELAND UNN NTNU OUS Untitled
 
2014
27 Kolstad, Arne; Laurell, Anna; Jerkeman, Mats; Gronbaek, Kirsten; Elonen, Erkki; Räty, Riikka; Pedersen, Lone Bredo; Loft, Annika; Bogsrud, Trond; Kimby, Eva; Hansen, Per Boye; Fagerli, Unn-Merete; Nilsson-Ehle, Herman; Lehmann, Anne Kristine; Sundström, Christer; Lauritzsen, Grete Fossum; Karjalainen-Lindsberg, Marja-Liisa; Ralfkiaer, Elisabeth; Ehinger, Mats; Delabie, Jan; Bentzen, Hans; Schildt, Jukka; Kostova-Aherdan, Kamelia; Frederiksen, Henrik; Brown, Peter de Nully; Geisler, Christian H..
Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma. Blood 2014 ;Volum 123.(19) s. 2953-2959
STO OUS HAUKELAND Untitled
 
2013
28 Rø, Torstein Baade; Holien, Toril; Fagerli, Unn-Merete; Hov, Håkon; Misund, Kristine; Waage, Anders; Sundan, Anders; Holt, Randi Anny Utne; Børset, Magne.
HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase. Experimental Hematology 2013 ;Volum 41.(7) s. 646-655
NTNU STO Untitled
 
29 Smeland, Knut Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Blystad, Anne Kirsti; Fagerli, Unn Merete; Fluge, Øystein; Fosså, Alexander; Hammerstrøm, Jens; Kolstad, Arne; Loge, Jon; Maisenhölder, Martin; Østenstad, Bjørn; Kvaløy, Stein Olav; Holte, Harald.
Høydosebehandling med autolog stamcellestøtte ved lymfom i Norge 1987 - 2008. Tidsskrift for Den norske legeforening 2013 ;Volum 133.(16) s. 1704-1709
OUS NTNU STO HAUKELAND UiO UNN Untitled
 
30 Smeland, Knut Halvor Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Blystad, Anne Kirsti; Fagerli, Unn-Merete; Fluge, Øystein; Fosså, Alexander; Hammerstrøm, Jens; Kolstad, Arne; Loge, Jon Håvard; Maisenhölder, Martin; Østenstad, Bjørn; Kvaløy, Stein Olav; Holte, Harald.
High dose therapy with autologous stem cell support for lymphoma in Norway 1987-2008. Tidsskrift for Den norske legeforening 2013 ;Volum 133.(16) s. 1704-1709
NTNU OUS UiO UiB UNN Untitled
 
31 Smeland, Knut Halvor Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Fosså, Alexander; Hammerstrøm, Jens; Fagerli, Unn-Merete; Jetne, Vidar; Kolstad, Arne; Kvalheim, Gunnar; Loge, Jon Håvard; Løkeland, Turid; Tangen, Jon-Magnus; Holte, Harald; Kvaløy, Stein Olav.
High dose therapy with autologous stem cell support for lymphoma-from experimental to standard treatment. Tidsskrift for Den norske legeforening 2013 ;Volum 133.(16) s. 1735-1739
NTNU OUS UiO HAUKELAND Untitled
 
2012
32 Arne, Kolstad; Laurell, Anna; Jerkeman, Mats; Grønbæk, Kirsten; Elonen, Erkki; Räty, Riikka; Pedersen, Lone Bredo; Loft, Annika; Bogsrud, Trond; Nordstrøm, Marianne; Hansen, Per Boye; Fagerli, Unn-Merete; Nilsson-Ehle, Herman; Lauritzsen, Grete Fossum; Lehmann, Anne Kristine; Sundström, Christer; Karjalainen-Lindsberg, Marja-Liisa; Ralfkiaer, Elisabeth; Ehinger, Mats; Delabie, Jan; Bentzen, Hans; Schildt, Jukka; Kostova-Aherdan, Kamelia; Frederiksen, Henrik; Brown, Peter de Nully; Geisler, Christian H..
Nordic MCL3 Study: Zevalin Combined with High-Dose Chemotherapy Followed by Autologous Stem Cell Support As Late Intensification for Mantle Cell Lymphoma (MCL) Patients &lt; 66 Years Not in CR After Induction Chemoimmunotherapy: No Benefit of Zevalin. Blood 2012 ;Volum 120.(21) s. -
OUS STO HAUKELAND Untitled
 
33 Børset, Magne; Holt, Randi Utne; Slørdahl, Tobias Schmidt; Holien, Toril; Dai, Hong Yan; Sundan, Anders; Fagerli, Unn-Merete.
PRL-3 - A Microenvironment-responsive Phosphatase in Myeloma Cells with Oncogenic Capacity. BIT’s 1st Annual International Symposium of Hematology-2012 (AISH2012); 2012-06-15
NTNU STO Untitled
 
34 d'Amore, Francesco; Leppä, Sirpa; da Silva, Maria Gomes; Relander, Thomas; Brown, Peter de Nully; Weidmann, Eckhart; Lauritzsen, Grete Fossum; Pezzutto, Antonio; Van Hoof, Achiel; van Gelder, Michel; Doorduijn, Jeanette K.; Wu, Ka Lung; Kluin-Nelemans, J. C.; Lugtenburg, P. J.; Jankovska, Milada; Merup, Mats; Fagerli, Unn-Merete; Walewski, Jan; Hagberg, Hans; Mariz, Jóse M.; Hansen, Per Boye; Nösslinger, Thomas; Janssens, Ann; Brandefors, Lena; Demuynck, Hilde; Schaafsma, Martyn Ronald; Christiansen, Ilse; Salek, David; Jyrkkio, Sirkku.
First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy. Blood 2012 ;Volum 120.(21) s. -
OUS STO Untitled
 
35 d'Amore, Francesco; Relander, Thomas; Lauritzsen, Grete Fossum; Jantunen, Esa; Hagberg, Hans; Anderson, Harald; Holte, Harald; Österborg, Anders; Merup, Mats; Brown, Peter de Nully; Kuittinen, Outi; Erlanson, Martin; Østenstad, Bjørn; Fagerli, Unn-Merete; Gadeberg, Ole Vestergaard; Sundström, Christer; Delabie, Jan; Ralfkiaer, Elisabeth; Vornanen, Martine; Toldbod, Heller Erbs.
Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01. Journal of Clinical Oncology 2012 ;Volum 30.(25) s. 3093-3099
OUS STO Untitled
 
36 Wader, Karin Fahl; Fagerli, Unn-Merete; Børset, Magne; Lydersen, Stian; Hov, Håkon; Sundan, Anders; Bofin, Anna M.; Waage, Anders.
Immunohistochemical analysis of hepatocyte growth factor and c-Met in plasma cell disease. Histopathology 2012 ;Volum 60.(3) s. 443-451
NTNU STO Untitled
 
2011
37 Eide, Marianne Brodtkorb; Lauritzsen, Grete Fossum; Kvalheim, Gunnar; Kolstad, Arne; Fagerli, Unn-Merete; Maisenhölder, Martin; Østenstad, Bjørn; Fluge, Øystein; Delabie, Jan; Aarset, Harald; Liestøl, Knut; Holte, Harald.
High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study. British Journal of Haematology 2011 ;Volum 152.(5) s. 600-610
OUS UNN UiO STO HAUKELAND Untitled
 
38 Fagerli, Unn-Merete; Ullrich, K; Stühmer, Thorsten; Holien, Toril; Köchert, K; Holt, Randi Utne; Bruland, Ove; Chatterjee, Manik; Nogai, H; Lenz, G; Shaughnessy, JD; Mathas, Stephan; Sundan, Anders; Bargou, Ralf C.; Dörken, Bernd; Børset, Magne; Janz, Martin.
Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells. Oncogene 2011 ;Volum 30.(28) s. 3198-3206
NTNU STO HAUKELAND Untitled
 
39 Rø, Torstein Baade; Holt, Randi Utne; Holien, Toril; Fagerli, Unn-Merete; Hov, Håkon; Waage, Anders; Sundan, Anders; Børset, Magne.
HGF AND IGF-1 POTENTIATE SDF-1 ALPHA-MEDIATED MYELOMA CELL MIGRATION THROUGH ACTIVATION OF PAK. 13th international myeloma workshop; 2011-05-04 - 2011-05-08
NTNU Untitled
 
40 Wader, Karin Fahl; Fagerli, Unn-Merete; Holt, Randi Utne; Børset, Magne; Sundan, Anders; Waage, Anders.
Soluble c-Met in serum of patients with multiple myeloma: correlation with clinical parameters. European Journal of Haematology 2011 ;Volum 87.(5) s. 394-399
NTNU STO Untitled
 
2010
41 Fagerli, Unn-Merete; Stühmer, Thorsten; Holien, Toril; Holt, Randi Utne; Bruland, Ove; Chatterjee, Manik; Shaughnessy, John D.; Mathas, Stephan; Sundan, Anders; Bargou, Ralf C.; Dörken, Bernd; Børset, Magne; Janz, Martin.
Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) Is a Prominent Target Gene of the Transcriptional Response to Cytokines In Multiple Myeloma and Supports the Growth of Myeloma Cells. ASH Annual Meeting 2010; 2010-12-04 - 2010-12-07
NTNU STO UiB Untitled
 
42 Fagerli, Unn-Merete; Stühmer, Thorsten; Holien, Toril; Holt, Randi Utne; Bruland, Ove; Chatterjee, Manik; Shaughnessy, John D.; Mathas, Stephan; Sundan, Anders; Bargou, Ralf C.; Dörken, Bernd; Børset, Magne; Janz, Martin.
Serum/Glucocorticoid-Regulated Kinase 1 (SGK1) Is a Prominent Target Gene of the Transcriptional Response to Cytokines In Multiple Myeloma and Supports the Growth of Myeloma Cells. Blood 2010 ;Volum 116.(21) s. 798-799
NTNU HAUKELAND STO Untitled
 
43 Jantunen, Esa; Relander, Thomas; Lauritzsen, Grete Fossum; Hagberg, Hans; Anderson, Harald; Cavallin-Stahl, Eva; Holte, Harald; Österborg, Anders; Merup, Mats; Brown, Peter de Nully; Kuittinen, Outi; Erlanson, Martin; Østenstad, Bjørn; Fagerli, Unn-Merete; Gadeberg, Ole Vestergaard; Sundström, Christer; Delabie, Jan; Ralfkiær, Elisabeth; Vornanen, Martine; d'Amore, Francesco.
Intensive Induction Chemotherapy Followed by Autologous. Stem Cell Transplantation (ASCT) In Patients with Enteropathy-Associated T-Cell Lymphoma: a Prospective Study by the Nordic Lymphoma Group (NLG-T-01). Blood 2010 ;Volum 116.(21) s. 1467-1467
OUS STO Untitled
 
44 Relander, Thomas; Lauritzsen, Grete Fossum; Jantunen, Esa; Hagberg, Hans; Anderson, Harald; Cavallin-Ståhl, Eva; Holte, Harald; Österborg, Anders; Merup, Mats; Brown, Peter de Nully; Østenstad, Bjørn; Kuittinen, Outi; Erlanson, Martin; Fagerli, Unn-Merete; Gadeberg, Ole Vestergaard; Sundström, Christer; Delabie, Jan; Ralfkiær, Elisabeth; Vornanen, Martine; d'Amore, Francesco.
Favorable Outcome In ALK-Negative Anaplastic Large-Cell Lymphoma Following Intensive Induction Chemotherapy and Autologous Stem Cell Transplantation (ASCT): a Prospective Study by the Nordic Lymphoma Group (NLG-T-01). Blood 2010 ;Volum 116.(21) s. 1467-1467
OUS STO Untitled
 
2009
45 Hov, Håkon; Tian, Erming; Holien, Toril; Holt, Randi Utne; Våtsveen, Thea; Fagerli, Unn-Merete; Waage, Anders; Børset, Magne; Sundan, Anders.
c-Met signaling promotes IL-6-induced myeloma cell proliferation. European Journal of Haematology 2009 ;Volum 82.(4) s. 277-287
NTNU Untitled
 
46 Brenne, Anne-Tove; Fagerli, Unn Merete; Shaughnessy, JD; Våtsveen, Thea Kristin; Rø, Torstein Baade; Hella, Hanne; Zhan, Fenghuang; Barlogie, Bart; Sundan, Anders; Børset, Magne; Waage, Anders.
High expression of BCL3 in human myeloma cells is associated with increased proliferation and inferior prognosis. European Journal of Haematology 2009 ;Volum 82.(5) s. 354-363
NTNU Untitled
 
47 Fagerli, Unn-Merete.
Multiple myeloma cells and cytokines from the bone marrow environment; aspects of growth regulation and migration. Trondheim: NTNU 2009 (ISBN 978-82-471-1748-4)
NTNU Untitled
 
48 Holt, Randi Utne; Fagerli, Unn-Merete; Holien, Toril; Hov, Håkon; Waage, Anders; Sundan, Anders; Børset, Magne.
HGF AND IGF-1 POTENTIATE SDF-1 MEDIATED MYELOMA CELL MIGRATION THROUGH ACTIVATION OF PAK. Haematologica 2009 ;Volum 94. s. 376-376
NTNU STO Untitled
 
49 Holt, Randi Utne; Fagerli, Unn-Merete; Holien, Toril; Hov, Håkon; Waage, Anders; Sundan, Anders; Børset, Magne.
HGF and IGF-1 potentiate SDF-1 mediated myeloma cell migration through activation of PAK. European Hematology Association 14th Congress; 2009-06-04 - 2009-06-07
NTNU Untitled
 
50 Hov, Håkon; Tian, Erming; Holien, Toril; Holt, Randi Utne; Våtsveen, Thea; Fagerli, Unn-Merete; Waage, Anders; Sundan, Anders; Børset, Magne.
c-Met signaling promotes IL-6 induced myeloma cell proliferation. European Hematology Association 14th Congress; 2009-06-04 - 2009-06-07
NTNU Untitled
 
    Vis neste liste